معرفی
Roger Olsson is a Professor at Lund University, leading research at the intersection of bioelectronic medicine, organic electronics, and neuroscience. He serves as Principal Investigator at multiple Lund-based centers, including LUCC: Lund University Cancer Centre, MultiPark (Parkinson's disease research), and NanoLund (nanoscience). His work focuses on developing self-assembled organic electronic circuits that integrate with the nervous system to treat brain disorders, spinal cord injuries, and cardiac arrhythmias using locust and zebrafish models.
- Affiliations: Faculty of Medicine (Lund University), Centre for Analysis and Synthesis (visiting professor), NanoLund, MultiPark, LUCC
- Research Themes: Bioelectronic medicine, neuroprosthetics, regenerative therapies, nanotechnology applications in pharmacology
- Projects:
- Dynamic Oncoelectronics: Electrifying the Abscopal Effect (2025-2028, Cancerfonden)
- BICS: Bioresorbable Injectable Cardiac Stimulator (2024-2026, Novo Nordisk Foundation)
- In Situ Assembly of Organic Bioelectronics for Brain Redox Modulation (2024-2028, Swedish Research Council)
- Electronic Neuro-Pharmaceuticals (2018-2026, Swedish Research Council)
- e-NeuroPharma (2019-2024, Swedish Foundation for Strategic Research)
- Infrastructure: Manager of Chemical Biology Consortium Sweden – Lund
Recent Publications highlight innovations in in situ bioelectronic device assembly, including injectable cardiac stimulators (2024) and bioresorbable brain implants (2023), with collaborations spanning organic material synthesis, conducting polymer design, and cancer stem cell characterization (2022). His work aligns with UN SDGs for healthcare innovation and sustainable medical technologies.
